Publicaciones en colaboración con investigadores/as de Istituto Superiore di Sanità (74)

2024

  1. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

    The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307

2023

  1. Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes

    Frontiers in Oncology, Vol. 13

2022

  1. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials

    Frontiers in Oncology, Vol. 12

2020

  1. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

    Archives of Gynecology and Obstetrics, Vol. 301, Núm. 2, pp. 591-602

2019

  1. Epidemiology of rare cancers and inequalities in oncologic outcomes

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 3-11

  2. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 75-80

  3. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 60-66

  4. Treatment challenges in and outside a network setting: Head and neck cancers

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 40-45

  5. Treatment challenges in and outside a network setting: Soft tissue sarcomas

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 31-39

  6. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 46-51

2018

  1. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?

    European Journal of Cancer, Vol. 93, pp. 127-137

2017

  1. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

    The Lancet Oncology, Vol. 18, Núm. 8, pp. 1022-1039

  2. Data quality in rare cancers registraton: The report of the RARECARE data quality study

    Tumori, Vol. 103, Núm. 1, pp. 22-32

  3. Geographical variability in survival of European children with central nervous system tumours

    European Journal of Cancer, Vol. 82, pp. 137-148

  4. New insights into survival trend analyses in cancer population-based studies: The SUDCAN methodology

    European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S9-S15

  5. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study

    European Journal of Cancer, Vol. 84, pp. 335-353

  6. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5

    European Journal of Cancer, Vol. 77, pp. 140-152

  7. Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material

    European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S3-S8

  8. Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study

    European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S85-S91

  9. Trends in net survival from cervical cancer in six European Latin countries: Results from the SUDCAN population-based study

    European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S92-S99